Metformin - its potential anti-cancer and anti-aging effects - PubMed

Affiliations

• PMID: 28258677
• DOI: 10.5604/01.3001.0010.3801

Free article

Review

Metformin - its potential anti-cancer and anti-aging effects

Monika Podhorecka et al. Postepy Hig Med Dosw (Online). 2017.

Free article

Abstract

The generally accepted mechanism of metformin's effect is stimulation of adenosine monophosphate (AMP)-activated protein kinase (AMPK). AMPK is directly activated by an increase in AMP:ATP ratio in metabolic stress conditions including hypoxia and glucose deprivation. Lately, many novel pathways, besides AMPK induction, have been revealed, which can explain some of metformin's beneficial effects. It may help to identify new targets for treatment of diabetes and metabolic syndrome. Moreover, metformin is now attracting the attention of researchers in fields other than diabetes, as it has been shown to have anti-cancer, immunoregulatory and anti-aging effects. The aim of this review is to describe the potential anti-cancer and anti-aging properties of metformin and discuss the possible underlying mechanisms.

Similar articles

• Metformin and cancer.

  Vallianou NG, Evangelopoulos A, Kazazis C. Vallianou NG, et al. Rev Diabet Stud. 2013 Winter;10(4):228-35. doi: 10.1900/RDS.2013.10.228. Epub 2014 Feb 10. Rev Diabet Stud. 2013. PMID: 24841876 Free PMC article. Review.

• Role of AMP-activated protein kinase in mechanism of metformin action.

  Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Zhou G, et al. J Clin Invest. 2001 Oct;108(8):1167-74. doi: 10.1172/JCI13505. J Clin Invest. 2001. PMID: 11602624 Free PMC article.

• Metabolic roles of AMPK and metformin in cancer cells.

  Choi YK, Park KG. Choi YK, et al. Mol Cells. 2013 Oct;36(4):279-87. doi: 10.1007/s10059-013-0169-8. Epub 2013 Jun 19. Mol Cells. 2013. PMID: 23794020 Free PMC article. Review.

• Pharmacologic mechanisms underlying antidiabetic drug metformin's chemopreventive effect against colorectal cancer.

  Jaromy M, Miller JD. Jaromy M, et al. Eur J Pharmacol. 2021 Apr 15;897:173956. doi: 10.1016/j.ejphar.2021.173956. Epub 2021 Feb 19. Eur J Pharmacol. 2021. PMID: 33617821 Review.

• New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway.

  Hsu SK, Cheng KC, Mgbeahuruike MO, Lin YH, Wu CY, Wang HD, Yen CH, Chiu CC, Sheu SJ. Hsu SK, et al. Int J Mol Sci. 2021 Aug 31;22(17):9453. doi: 10.3390/ijms22179453. Int J Mol Sci. 2021. PMID: 34502359 Free PMC article. Review.

Cited by

• Tumor reversion: a dream or a reality.

  Tripathi A, Kashyap A, Tripathi G, Yadav J, Bibban R, Aggarwal N, Thakur K, Chhokar A, Jadli M, Sah AK, Verma Y, Zayed H, Husain A, Bharti AC, Kashyap MK. Tripathi A, et al. Biomark Res. 2021 May 6;9(1):31. doi: 10.1186/s40364-021-00280-1. Biomark Res. 2021. PMID: 33958005 Free PMC article. Review.

• Metformin suppresses proliferation and differentiation induced by BMP9 via AMPK signaling in human fetal lung fibroblast-1.

  Chen Q, Wang Y, Sheng L, Huang Y. Chen Q, et al. Front Pharmacol. 2022 Aug 24;13:984730. doi: 10.3389/fphar.2022.984730. eCollection 2022. Front Pharmacol. 2022. PMID: 36091775 Free PMC article.

• Epithelial-mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model.

  Veloso ES, de Carvalho BA, de Souza Silva FH, Ribeiro TS, Lima BM, Almeida CP, da Silva VHSR, Rocha SA, de Araújo Campos MR, Del Puerto HL, Ferreira E. Veloso ES, et al. Sci Rep. 2022 Oct 22;12(1):17776. doi: 10.1038/s41598-022-22235-8. Sci Rep. 2022. PMID: 36273071 Free PMC article.

• The role of AMPK/mTOR signaling pathway in anticancer activity of metformin.

  Chomanicova N, Gazova A, Adamickova A, Valaskova S, Kyselovic J. Chomanicova N, et al. Physiol Res. 2021 Aug 31;70(4):501-508. doi: 10.33549/physiolres.934618. Epub 2021 Jun 1. Physiol Res. 2021. PMID: 34062070 Free PMC article. Review.

• Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis.

  Deng H, Qian X, Zhang Y, Yu W, Yang P. Deng H, et al. Dig Dis Sci. 2024 Feb;69(2):476-490. doi: 10.1007/s10620-023-08210-x. Epub 2024 Jan 3. Dig Dis Sci. 2024. PMID: 38170336

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • IndexCopernicus

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information